MTX-naïve early RA pts with poor prognostic factors entered C-OPERA trial & Rx w/ Cimzia or MTX or CZP/MTX x 1 yrs adn Rx was W/D in yr 2. Those most likely to withdraw from CZP therapy had low disease activity and low RF levels (median <50IU) https://t.co/3O337o7kiw